Canonical Wnt signaling activates miR-34 expression during osteoblastic differentiation

Tamura,Masato; Uyama,Maki; Sugiyama,Yuri; Sato,Mari

doi:10.3892/mmr.2013.1713

Canonical Wnt signaling activates miR-34 expression during osteoblastic differentiation

Authors:
- Masato Tamura
- Maki Uyama
- Yuri Sugiyama
- Mari Sato
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, Graduate School of Dental Medicine, Hokkaido University, Kita‑ku, Sapporo 060-8586, Japan
Published online on: October 4, 2013 https://doi.org/10.3892/mmr.2013.1713
Pages: 1807-1811

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The canonical Wnt signaling pathway is crucial for the regulation of bone mass in humans and for the development of osteoblasts. MicroRNAs (miRs) represent a class of non‑coding RNAs, ~22 nucleotides in length, that regulate gene expression by targeting mRNAs for cleavage or translational repression. Several previous studies have demonstrated the involvement of miRNAs in modulating gene expression in osteoblasts and regulating osteoblast differentiation. In the present study, microRNA profiling was conducted using Wnt3a‑C2C12 cells; C2C12 cells were transfected with a Wnt3a expression plasmid to activate canonical Wnt signaling. miR‑34b‑5p and miR‑34c were identified to be upregulated by the activation of canonical Wnt signaling in C2C12 cells. Expression of mature miR‑34b/c increased from low levels at day 0 to maximum levels at day 28 of MC3T3‑E1 cell differentiation. To analyze the effects of these miRNAs on osteoblast differentiation, an antisense inhibitor was transfected into MC3T3‑E1 cells and osteoblast‑related gene expression was investigated. Knockdown of miR34b/c enhanced osteocalcin mRNA expression; however, alkaline phosphatase mRNA expression and activity were decreased by miR34b/c inhibition. These results indicated that miR‑34b/c regulates gene expression by targeting regulators of the osteogenic pathways and thereby contributes to osteoblast differentiation.

View Figures

View References

1	Young MF: Bone matrix proteins: more than markers. Calcif Tissue Int. 72:2–4. 2003. View Article : Google Scholar : PubMed/NCBI
2	Ortega N, Behonick DJ and Werb Z: Matrix remodeling during endochondral ossification. Trends Cell Biol. 14:86–93. 2004. View Article : Google Scholar : PubMed/NCBI
3	Canalis E: Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab. 95:1496–1504. 2010. View Article : Google Scholar : PubMed/NCBI
4	Krishnan V, Bryant H and Macdougald OA: Regulation of bone mass by Wnt signaling. J Clin Invest. 116:1202–1209. 2006. View Article : Google Scholar : PubMed/NCBI
5	Tamura M, Nemoto E, Sato MM, Nakashima A and Shimauchi H: Role of the Wnt signaling pathway in bone and tooth. Front Biosci (Elite Ed). 2:1405–1413. 2010. View Article : Google Scholar : PubMed/NCBI
6	Sato M, Nakashima A, Nashimoto M, Yawaka Y and Tamura M: Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression. Genes Cells. 14:141–153. 2009. View Article : Google Scholar : PubMed/NCBI
7	Filipowicz W, Bhattacharyya S and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114. 2008. View Article : Google Scholar : PubMed/NCBI
8	Ding XC, Weiler J and Grosshans H: Regulating the regulators: mechanisms controlling the maturation of microRNAs. Trends Biotechnol. 27:27–36. 2009. View Article : Google Scholar : PubMed/NCBI
9	Sayed D and Abdellatif M: MicroRNAs in development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
10	Williams AE: Functional aspects of animal microRNAs. Cell Mol Life Sci. 65:545–562. 2008. View Article : Google Scholar : PubMed/NCBI
11	Sato M, Nashimoto M, Katagiri T, Yawaka Y and Tamura M: Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process. Biochem Biophys Res Commun. 383:125–129. 2009. View Article : Google Scholar : PubMed/NCBI
12	Kapinas K, Kessler CB and Delany AM: miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem. 108:216–224. 2009. View Article : Google Scholar : PubMed/NCBI
13	Kapinas K, Kessler C, Ricks T, Gronowicz G and Delany AM: miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem. 285:25221–25231. 2010. View Article : Google Scholar : PubMed/NCBI
14	Schoolmeesters A, Eklund T, Leake D, et al: Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS One. 4:e56052009. View Article : Google Scholar : PubMed/NCBI
15	Itoh T, Nozawa Y and Akao Y: MicroRNA-141 and −200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem. 284:19272–19279. 2009.
16	Hu R, Liu W, Li H, et al: A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem. 286:12328–12339. 2011. View Article : Google Scholar : PubMed/NCBI
17	Hassan MQ, Gordon JA, Beloti MM, et al: A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA. 107:19879–19884. 2010. View Article : Google Scholar : PubMed/NCBI
18	Eskildsen T, Taipaleenmäki H, Stenvang J, et al: MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA. 108:6139–6144. 2011. View Article : Google Scholar : PubMed/NCBI
19	Zhang Y, Xie RL, Croce CM, et al: A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci USA. 108:9863–9868. 2011. View Article : Google Scholar : PubMed/NCBI
20	Nakashima A, Katagiri T and Tamura M: Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J Biol Chem. 280:37660–37668. 2005. View Article : Google Scholar : PubMed/NCBI
21	Uyama M, Sato MM, Kawanami M and Tamura M: Regulation of osteoblastic differentiation by the proteasome inhibitor bortezomib. Genes Cells. 17:548–558. 2012. View Article : Google Scholar : PubMed/NCBI
22	Landgraf P, Rusu M, Sheridan R, et al: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 29:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
23	Lee Y, Kim M, Han J, et al: MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23:4051–4060. 2004. View Article : Google Scholar : PubMed/NCBI
24	Yochum G, McWeeney S, Rajaraman V, Cleland R, Peters S and Goodman RH: Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells. Proc Natl Acad Sci USA. 104:3324–3329. 2007. View Article : Google Scholar : PubMed/NCBI
25	Kim NH, Kim HS, Kim NG, et al: p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci Signal. 4:ra712011.PubMed/NCBI
26	Wei J, Shi Y, Zheng L, et al: miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol. 197:509–521. 2012. View Article : Google Scholar : PubMed/NCBI